Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
2
×
allergan
2
×
astrazeneca
2
×
biogen
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
ipo
life sciences
martin shkreli
national
national blog main
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
10x genomics
akouos
alnylam pharmaceuticals
amag pharmaceuticals
amgen
What
bio
roundup
acquisitions
announced
august
biotech
busy
ceo
collabs
covid
daniel
days
deal
decisions
devices
drugs
fda
gilead
gilead’s
help
introduce
ipo
legacy
medicines
month
news
nods
opioid
o’day
past
plans
regulatory
sarepta’s
sciences
seven
shkreli’s
slow
stumble
suits
tends
Language
unset
2
×
Current search:
abbvie
×
unset
×
astrazeneca
×
allergan
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More